Calculated blood loss at cesarean delivery in patients with preeclampsia with severe features on magnesium sulfate.

Introduction: Magnesium sulfate decreases the risk of eclampsia in patients with severe preeclampsia. There is a theoretical risk that magnesium sulfate increases the risk of intrapartum hemorrhage. We evaluated whether there was a quantitative difference in blood loss in patients receiving magnesium sulfate at the time of cesarean delivery (CD) compared to those who were not.

Outpatient versus inpatient management for superimposed preeclampsia without severe features: a retrospective, multicenter study.

Purpose: To determine if women with preterm superimposed preeclampsia without severe features can be successfully and safely triaged to outpatient management.

Materials And Methods: This was a multicenter, retrospective, cohort study of singleton pregnancies with superimposed preeclampsia without severe features diagnosed before 37 weeks managed outpatient versus inpatient at Thomas Jefferson University (Philadelphia, PA) and at University of Naples (Naples, Italy) from January 2008 to July 2015. The attending physician made the decision to manage outpatient or inpatient at his or her discretion.

Blood loss at cesarean delivery in women on magnesium sulfate for preeclampsia.

Objective: To evaluate the effect of magnesium sulfate for prevention of eclampsia on blood loss at time of cesarean delivery (CD).

Methods: We conducted an electronic based search using the following databases: MEDLINE, PUBMED and the Cochrane Library. The search terms were "magnesium sulfate", "preeclampsia" and "randomized".